Duvelisib

Status:

Do Not Prescribe (DNP)

Decision Date:

None

Comments

DO NOT PRESCRIBE (DNP):

• NICE TA717 - for treating relapsed follicular lymphoma after 2 or more systemic therapies. (Terminated appraisal).  (Decision date - August 2021).
• NICE TA811 - for treating relapsed or refractory chronic lymphocytic leukaemia after 2 or more treatments.  (Terminated appraisal).  (Decision date - August 2022).

Black Drug Classifications

• 6: Have NICE guidance that recommends they should not be used

search again